|Articles|October 1, 2012
- Applied Clinical Trials-10-01-2012
- Volume 21
- Issue 10
Applied Clinical Trials Digital Edition - October 2012
CRO/SPONSOR : Outsourcing to China REGULATORY : Warning Letter Analysis CRO/SPONSOR : Customer Expectation Management Also in this issue : EU Pediatric Regulation, Healthcare Data Informs Research, Modeling and Simulation
Advertisement
Articles in this issue
almost 14 years ago
Business and News Update October 2012almost 14 years ago
Virtual Trials Come Under Growing Scrutinyalmost 14 years ago
EDC Autoquery Rate - A Marker for Site Qualityalmost 14 years ago
Warning Letter Studyalmost 14 years ago
Diagnostics Needed for Personalized Medicinealmost 14 years ago
Research, Practice, and Learningalmost 14 years ago
The Local Touchalmost 14 years ago
Managing Customer Expectationsalmost 14 years ago
Act Coveralmost 14 years ago
Site-Cost Line Item Charges on the RiseAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
3
ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value
4
Protocol Design Doesn't Fail in the Protocol, It Fails in Transition to Trial
5